Get the Stockscreener App
5.70
1.04%
-0.06
Bolt Biotherapeutics Inc stock is traded at $5.70, with a volume of 13,952.
It is down -1.04% in the last 24 hours and up +7.34% over the past month.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
See More
Previous Close:
$5.76
Open:
$5.72
24h Volume:
13,952
Relative Volume:
0.64
Market Cap:
$10.94M
Revenue:
$4.17M
Net Income/Loss:
$-50.71M
P/E Ratio:
-0.423
EPS:
-13.474
Net Cash Flow:
$-51.40M
1W Performance:
-8.65%
1M Performance:
+7.34%
6M Performance:
-19.38%
1Y Performance:
-56.72%
1-Day Range:
$5.61
$5.904
1-Week Range:
$5.61
$6.20
52-Week Range:
$4.59
$13.80
Bolt Biotherapeutics Inc Stock (BOLT) Company Profile
Name
Bolt Biotherapeutics Inc
Sector
Industry
Phone
650-665-9295
Address
900 CHESAPEAKE DRIVE, REDWOOD CITY
Compare BOLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics Inc
|
5.70 | 11.06M | 4.17M | -50.71M | -51.40M | -13.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.83 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.76 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.40 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
821.96 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.94 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Resumed | H.C. Wainwright | Buy |
| Jan-06-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-02-21 | Initiated | Guggenheim | Buy |
| Mar-02-21 | Initiated | Morgan Stanley | Overweight |
| Mar-02-21 | Initiated | SVB Leerink | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Bolt Biotherapeutics Inc Stock (BOLT) Latest News
Will Bolt Biotherapeutics Inc. stock reach Wall Street targetsOptions Play & Weekly Chart Analysis and Guides - newser.com
What MACD and RSI say about Bolt Biotherapeutics Inc.Weekly Profit Report & Weekly Breakout Opportunity Watchlist - newser.com
Why Bolt Biotherapeutics Inc. (6LP0) stock signals breakout potential2025 Top Gainers & Daily Volume Surge Signals - newser.com
Risk adjusted return profile for Bolt Biotherapeutics Inc. analyzedTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com
Can Bolt Biotherapeutics Inc. rally from current levelsTrade Performance Summary & Verified High Yield Trade Plans - newser.com
How Bolt Biotherapeutics Inc. stock reacts to bond yieldsJuly 2025 Intraday Action & Precise Entry and Exit Recommendations - newser.com
What dividend safety score for Bolt Biotherapeutics Inc. stockTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
Is Bolt Biotherapeutics Inc. (6LP0) stock a good hedge against inflationWeekly Market Summary & Weekly High Potential Stock Alerts - newser.com
Building trade automation scripts for Bolt Biotherapeutics Inc.Trade Ideas & Daily Profit Maximizing Tips - newser.com
Does Bolt Biotherapeutics Inc. show high probability of reboundTrade Entry Summary & Stepwise Trade Execution Plans - newser.com
Is Bolt Biotherapeutics Inc. forming a reversal patternQuarterly Trade Summary & AI Powered Market Entry Ideas - newser.com
Developing predictive dashboards with Bolt Biotherapeutics Inc. data2025 Momentum Check & Technical Pattern Recognition Alerts - newser.com
Will Bolt Biotherapeutics Inc. (6LP0) stock attract long term capital inflows2025 Valuation Update & Growth-Oriented Investment Plans - newser.com
Technical analysis overview for Bolt Biotherapeutics Inc. stockSell Signal & AI Powered Market Entry Strategies - newser.com
Is Bolt Biotherapeutics Inc. stock undervalued vs historical averagesJuly 2025 Highlights & High Accuracy Investment Entry Signals - newser.com
Real time scanner hits for Bolt Biotherapeutics Inc. explained2025 Short Interest & Community Consensus Picks - newser.com
How Bolt Biotherapeutics Inc. (6LP0) stock correlates with oil marketsBond Market & AI Forecasted Entry and Exit Points - newser.com
Can Bolt Biotherapeutics' Step-Up Dosing Strategy For BDC-4182 Deliver In 2026? - RTTNews
Can Bolt Biotherapeutics Inc. (6LP0) stock test all time highsJuly 2025 Recap & Safe Capital Growth Stock Tips - newser.com
Bolt Biotherapeutics Inc Stock (BOLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):